Neurologic Manifestations  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT01261741 / 2010-020737-50: Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems

Completed
2
299
Europe
Memantine, Placebo
Merz Pharmaceuticals GmbH
Memory Disorder, Retention Disorder, Cognitive, Subjective Cognitive Impairment, Memory, Concentration or Attention Problems
08/11
09/11
NCT00200538: Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

Completed
2
52
Europe
memantine
Nantes University Hospital
Dementia
 
 
NCT01602185: Study of NMDA Antagonists and Neuropathic Pain

Completed
2
7
Europe
Dextromethorphan (drug used like antitussive), Memantine (drug used in Alzheimer's disease), Placebo (lactose)
University Hospital, Clermont-Ferrand, Dr Malou Navez, Pain Clinic, Saint-Etienne Hopital, Dr Marc Sorel, Pain Clinic, Nemours Hospital, Dr Anne-Margot Duclot, Pain Clinic, Paris Rotschild Hospital, Dr Monique Belon, Pain Clinic, Aurillac Hospital, Dr Marie-Christine Crosmary/Dr Renato Colamarino, Pain Clinic, Vichy Hospital, Dr Mohamed El Ayadi, Pain Clinic, Issoire Hospital, Dr Géraldine Brumauld de Montgazon, Pain Clinic, La Rochelle Hospital
Neuropathic Pain
06/14
09/16

Download Options